| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/04/2009 | US7569050 Infusion device and method with drive device in infusion device and method with drive device in separable durable housing portion |
| 08/04/2009 | US7569049 Multi-stable valves for medical applications and methods for use thereof |
| 08/04/2009 | US7569034 Low profile pivoting joint infusion assembly |
| 08/04/2009 | US7569030 Safety limits for closed-loop infusion pump control |
| 08/04/2009 | US7569025 Methods and devices for treating severe peripheral bacterial infections |
| 08/04/2009 | CA2566440C An antimycobacterial pharmaceutical composition |
| 08/04/2009 | CA2523987C Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery |
| 08/04/2009 | CA2462606C Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer |
| 08/04/2009 | CA2420348C Non-hormonal vaginal contraceptive |
| 08/04/2009 | CA2411047C Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| 08/04/2009 | CA2392367C Composition and method for treatment of otitis media |
| 08/04/2009 | CA2347447C Buffered compositions for dialysis |
| 08/04/2009 | CA2272237C Film coatings and film coating compositions based on dextrin |
| 08/04/2009 | CA2243649C Bioresponsive pharmacologically-active polymers and articles made therefrom |
| 08/04/2009 | CA2222323C Vascularized tissue regeneration matrices formed by solid free-form fabrication methods |
| 08/04/2009 | CA2221110C Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension |
| 08/04/2009 | CA2207850C Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
| 08/03/2009 | WO2006079903A1 Antacid lozenge containing micronized salts |
| 08/03/2009 | CA2595984A1 Antacid lozenge containing micronized salts |
| 07/30/2009 | WO2009094580A2 Nano-devices having releasable seals for controlled release of molecules |
| 07/30/2009 | WO2009094466A2 Contact lenses for extended release of bioactive agents containing diffusion attenuators |
| 07/30/2009 | WO2009094191A2 Methods of treating viral infections |
| 07/30/2009 | WO2009094190A2 Methods of treating viral infections |
| 07/30/2009 | WO2009094181A1 Ph-responsive nanostructures |
| 07/30/2009 | WO2009093928A1 Agent for leg care against in case of chronic venous insufficiency of lower extremities |
| 07/30/2009 | WO2009093736A1 Tablet comprising kanpo herbal medicine and pantethine component |
| 07/30/2009 | WO2009093713A1 Peg-modified hydroxyapatite, pharmaceutical preparation containing the same as base material, and method for production of the same |
| 07/30/2009 | WO2009093650A1 Prostaglandin-containing fat emulsion and method for producing the same |
| 07/30/2009 | WO2009093595A1 Method for producing carotenoid-containing emulsion composition, carotenoid-containing emulsion composition obtained by the same, carotenoid-containing powder composition, and functional food and cosmetic preparation each containing the composition |
| 07/30/2009 | WO2009093540A1 Chlorine dioxide liquid preparation composition |
| 07/30/2009 | WO2009092819A1 Combination of oral medicaments bonded by a wrapping |
| 07/30/2009 | WO2009092818A1 Abuse resistant melt extruded formulation having reduced alcohol interaction |
| 07/30/2009 | WO2009092703A1 Method for lyophilising particles having a pharmaceutical compound contained therein and a pharmaceutical pack containing such particles |
| 07/30/2009 | WO2009092601A1 Pharmaceutical dosage form |
| 07/30/2009 | WO2009092571A2 Bubbles and method for producing and manipulating bubbles |
| 07/30/2009 | WO2009092516A2 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| 07/30/2009 | WO2009092377A1 Compressed chewing gum comprising sterol |
| 07/30/2009 | WO2009092333A1 Device and process for preparing sodium alginate/chitosan slow release capsules with high efficiency |
| 07/30/2009 | WO2009092291A1 A drug delivery system, its preparation process and use |
| 07/30/2009 | WO2009074286A3 Pharmaceutical formulation comprising ezetimibe |
| 07/30/2009 | WO2009073612A3 Homeopathic remedies for use before and after aesthetic injectable and surgical procedures to minimize swelling and bruising |
| 07/30/2009 | WO2009067536A3 Formulation for decreasing tobacco, alcohol, drug or food consumption |
| 07/30/2009 | WO2009064460A3 Gastrointestinal delivery systems |
| 07/30/2009 | WO2009063222A3 Solid compositions |
| 07/30/2009 | WO2009062136A3 Controlled delivery of insulin from thermo-sensitive polymer solution |
| 07/30/2009 | WO2009053576A3 Coating composition comprising polydextrose, process for preparing same and use for coating ingestible solid forms |
| 07/30/2009 | WO2009048594A3 Multicomponent bioactive intravaginal ring |
| 07/30/2009 | WO2009034541A3 Controlled release pharmaceutical dosage forms of trimetazidine |
| 07/30/2009 | WO2009017716A3 Pulsatile gastric retentive dosage forms |
| 07/30/2009 | WO2009013633A4 Amorphous coprecipitates of atorvastatin pharmaceutically acceptable salts |
| 07/30/2009 | WO2009007273A3 A colouring composition comprising starch derivatives as a hydrocolloid |
| 07/30/2009 | WO2009000473A3 Effervescent tablets for inhalatory use |
| 07/30/2009 | WO2008154339A3 Extended release formulation and method of treating adrenergic dysregulation |
| 07/30/2009 | WO2008147438A3 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
| 07/30/2009 | WO2008121721A8 Targeted delivery and expression of procoagulant hemostatic activity |
| 07/30/2009 | WO2008098760A3 Solid pharmaceutical formulations of a homogeneous dispersion of active principles having ph-dependent solubility |
| 07/30/2009 | WO2008089771A8 Dna controlled assembly of lipid membranes |
| 07/30/2009 | WO2008040155A8 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 07/30/2009 | WO2007122465A3 Process for manufacturing films |
| 07/30/2009 | US20090192492 Sinus delivery of sustained release therapeutics |
| 07/30/2009 | US20090192491 Sinus delivery of sustained release therapeutics |
| 07/30/2009 | US20090192490 Sinus delivery of sustained release therapeutics |
| 07/30/2009 | US20090192489 Sinus delivery of sustained release therapeutics |
| 07/30/2009 | US20090192488 Sinus delivery of sustained release therapeutics |
| 07/30/2009 | US20090192230 Propofol-containing fat emulsion preparation |
| 07/30/2009 | US20090192214 Drug delivery from rapid gelling polymer composition |
| 07/30/2009 | US20090192185 Medical product |
| 07/30/2009 | US20090192183 Oxymorphone Controlled Release Formulations |
| 07/30/2009 | US20090192132 Pharmaceutical Composition |
| 07/30/2009 | US20090192131 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 07/30/2009 | US20090191277 Protein nanoparticles |
| 07/30/2009 | US20090191276 Colloidosomes having tunable properties and methods for making colloidosomes having tunable properties |
| 07/30/2009 | US20090191275 Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| 07/30/2009 | US20090191274 Pharmaceutical composition of amlodipine maleate having enhanced stability |
| 07/30/2009 | US20090191273 Metal Oxide Dispersion |
| 07/30/2009 | US20090191272 Use of vegetable fine grain sized fibres for preparing a nutritional composition for reducing mycotoxin bioavailability |
| 07/30/2009 | US20090191271 Topical Formulations |
| 07/30/2009 | US20090191270 a silicon oxide porous body having gold particles as coverings for the pores and connecting members comprised of variable regions of an antibody, that bind to the gold particles, used for controlled release of drugs at a prescribed site |
| 07/30/2009 | US20090191269 Use of gelatin and a cross-linking agent for producing a cross-linking therapeutic composition |
| 07/30/2009 | US20090191268 Allergy vaccines |
| 07/30/2009 | US20090191267 Oral Compositions Containing a Salivation Inducing Agent |
| 07/30/2009 | US20090191266 Pregelatinized Starch In A Controlled Release Formulation |
| 07/30/2009 | US20090191265 comprises 5-30% by wt of pharmaceutically acceptable excipients and 70-95% of 5-methyl-1-phenyl-2-(1H)-pyridone, where excipients comprise effective amount of binder to increase changes in blood concentration of pirfenidone upon oral administration, compared to capsule comprising no excipients; fibrosis |
| 07/30/2009 | US20090191264 Epothilone compositions |
| 07/30/2009 | US20090191263 Compositions and methods for sirna inhibition of hif-1 alpha |
| 07/30/2009 | US20090191262 Use of compounds of formula a-r-xo pharmaceutically acceptable salts thereof for producing a pharmaceutically preparations |
| 07/30/2009 | US20090191261 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 07/30/2009 | US20090191260 Aerosol and use thereof |
| 07/30/2009 | US20090191259 Efficient liposomal encapsulation |
| 07/30/2009 | US20090191257 Pain relief lollipop compositions and methods |
| 07/30/2009 | US20090191256 High water content ophthalmic devices |
| 07/30/2009 | US20090191254 Inhibition of biofilm formation using bacteriophage |
| 07/30/2009 | US20090191249 Sheet substrates impregnated with aromatic releasing compositions and a method of delivery of aromatic releasing compositions |
| 07/30/2009 | US20090191248 Hand health and hygiene system for hand health and infection control |
| 07/30/2009 | US20090191245 Reduced-irritant dermatological compositions comprising at least one naphthoic acid compound and benzoyl peroxide and treatment of keratinization disorders therewith |
| 07/30/2009 | US20090191244 Microbubbles and methods for oxygen delivery |
| 07/30/2009 | US20090191231 Prevention and treatment of amyloidogenic disease |
| 07/30/2009 | US20090191226 Adjuvant formulation comprising a submicron oil droplet emulsion |
| 07/30/2009 | US20090191217 Anti-IL-1R1 Single Domain Antibodies And Therapeutic Uses |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |